Mark Engel
CEO
Founded: Five successful life science companies since 1990; rich experience in new drug registrations and product commercialization
Companies established previously: NPO Pharmaceutical (sold), Excel PharmaStudies company (sold), Tiger Medical Group (sold), Haoyisheng ("Good Doctor") (largest shareholder and director), and Phagelux AgriHealth Inc. (largest shareholder and Chairman)
Mark established his own investment fund called Tianshi Capital that invests in life science and agricultural companies. See further www.tianshicapital.com